Neuroprotection as a Potential Therapeutic Perspective in Neurodegenerative Diseases: Focus on Antiepileptic Drugs.

about

Presynaptic GLP-1 receptors enhance the depolarization-evoked release of glutamate and GABA in the mouse cortex and hippocampus.

P2860

Q47266756-19928C17-4805-41CF-BC43-526C89A6ACF8

P2860

Neuroprotection as a Potential Therapeutic Perspective in Neurodegenerative Diseases: Focus on Antiepileptic Drugs.

Item

http://www.wikidata.org/entity/Q38684428

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Neuroprotection as a Potential ...... Focus on Antiepileptic Drugs.

@en

type

Item

label

Neuroprotection as a Potential ...... Focus on Antiepileptic Drugs.

@en

prefLabel

Neuroprotection as a Potential ...... Focus on Antiepileptic Drugs.

@en

P1476

Neuroprotection as a Potential ...... Focus on Antiepileptic Drugs.

@en

P2093

C Costa

http://www.w3.org/2001/XMLSchema#string

D Caccamo

http://www.w3.org/2001/XMLSchema#string

F Pisani

http://www.w3.org/2001/XMLSchema#string

L R Pisani

http://www.w3.org/2001/XMLSchema#string

P Mazzocchetti

http://www.w3.org/2001/XMLSchema#string

R Ientile

http://www.w3.org/2001/XMLSchema#string

P2860

Mitochondrial disturbances, excitotoxicity, neuroinflammation and kynurenines: Novel therapeutic strategies for neurodegenerative disorders

Molecular targets for antiepileptic drug development

Cellular models to investigate biochemical pathways in Parkinson's disease

Epigenetic mechanisms of chronic pain

Cellular stress responses, hormetic phytochemicals and vitagenes in aging and longevity

Animal models of traumatic brain injury

Intracellular calcium increase in epileptiform activity: modulation by levetiracetam and lamotrigine

Oxidative stress in neurodegeneration: cause or consequence?

Cellular stress responses, the hormesis paradigm, and vitagenes: novel targets for therapeutic intervention in neurodegenerative disorders

Nigrostriatal dopaminergic deficits and hypokinesia caused by inactivation of the familial Parkinsonism-linked gene DJ-1

P2888

s11064-015-1809-5

P304

340-352

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11064-015-1809-5

http://www.w3.org/2001/XMLSchema#string

P433

1-2

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Paolo Calabresi

P577

2015-12-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1014505840

http://www.w3.org/2001/XMLSchema#string

P698

26721507

http://www.w3.org/2001/XMLSchema#string

P921

neurodegeneration

Neuroprotection as a Potential Therapeutic Perspective in Neurodegenerative Diseases: Focus on Antiepileptic Drugs.

about

P2860

P2860

Neuroprotection as a Potential Therapeutic Perspective in Neurodegenerative Diseases: Focus on Antiepileptic Drugs.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P921

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P921